Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
Articolo
Data di Pubblicazione:
2019
Citazione:
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy / De Bleser, E.; Jereczek-Fossa, B. A.; Pasquier, D.; Zilli, T.; Van As, N.; Siva, S.; Fodor, A.; Dirix, P.; Gomez-Iturriaga, A.; Trippa, F.; Detti, B.; Ingrosso, G.; Triggiani, L.; Bruni, A.; Alongi, F.; Reynders, D.; De Meerleer, G.; Surgo, A.; Loukili, K.; Miralbell, R.; Silva, P.; Chander, S.; Di Muzio, N. G.; Maranzano, E.; Francolini, G.; Lancia, A.; Tree, A.; Deantoni, C. L.; Ponti, E.; Marvaso, G.; Goetghebeur, E.; Ost, P.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 76:6(2019), pp. 732-739. [10.1016/j.eururo.2019.07.009]
Abstract:
In treating nodal oligorecurrent prostate cancer, elective nodal radiotherapy reduces nodal relapse compared with stereotactic body radiotherapy. However, elective nodal radiotherapy was associated with higher toxicity.
Tipologia CRIS:
Articolo su rivista
Keywords:
Elective nodal radiotherapy; Metastasis-directed therapy; Oligometastasis; Oligorecurrence; Prostatic neoplasms; Radiotherapy; Recurrence; Stereotactic ablative body radiotherapy; Stereotactic body radiotherapy
Elenco autori:
De Bleser, E.; Jereczek-Fossa, B. A.; Pasquier, D.; Zilli, T.; Van As, N.; Siva, S.; Fodor, A.; Dirix, P.; Gomez-Iturriaga, A.; Trippa, F.; Detti, B.; Ingrosso, G.; Triggiani, L.; Bruni, A.; Alongi, F.; Reynders, D.; De Meerleer, G.; Surgo, A.; Loukili, K.; Miralbell, R.; Silva, P.; Chander, S.; Di Muzio, N. G.; Maranzano, E.; Francolini, G.; Lancia, A.; Tree, A.; Deantoni, C. L.; Ponti, E.; Marvaso, G.; Goetghebeur, E.; Ost, P.
Link alla scheda completa:
Pubblicato in: